Analysis of hospital incidence and direct medical costs of intrahepatic cholangiocarcinoma in Spain (2000-2018)

dc.contributor.authorDarbà, Josep
dc.contributor.authorMarsà, Alícia
dc.date.accessioned2021-06-10T20:45:48Z
dc.date.available2022-05-04T05:10:21Z
dc.date.issued2021-05-04
dc.date.updated2021-06-10T20:45:49Z
dc.description.abstractIntrahepatic cholangiocarcinomas (iCCA) are aggressive tumors, often diagnosed in advanced stages and with limited curative treatment options. Their incidence has raised in the past years, increasing their associated economic burden. This study aimed to measure hospital incidence and mortality of iCCA and to evaluate direct medical costs.
dc.format.extent-3822 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec703978
dc.identifier.issn1473-7167
dc.identifier.urihttps://hdl.handle.net/2445/178242
dc.language.isoeng
dc.publisherInforma Healthcare
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1080/14737167.2021.1842201
dc.relation.ispartofExpert Review of Pharmacoeconomics & Outcomes Research, 2021, vol. 21, núm. 3, p. 425-431
dc.relation.urihttps://doi.org/10.1080/14737167.2021.1842201
dc.rights(c) Informa Healthcare, 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Economia)
dc.subject.classificationCost de l'assistència sanitària
dc.subject.classificationGestió hospitalària
dc.subject.classificationHepatitis
dc.subject.classificationMalalties del fetge
dc.subject.otherCost of medical care
dc.subject.otherHospital administration
dc.subject.otherHepatitis
dc.subject.otherLiver diseases
dc.titleAnalysis of hospital incidence and direct medical costs of intrahepatic cholangiocarcinoma in Spain (2000-2018)
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
703978.pdf
Mida:
493.01 KB
Format:
Adobe Portable Document Format